AFG Bioscience LLC – Trademark Portfolio
Entity Type: 16
AFG Bioscience LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 5 trademarks are registered and 2 are pending. Notable registered marks include SIMPLEPHASE, AFG BIOSCIENCE, and AFG SCIENTIFIC. The owner is based in Northbrook, IL.
1818 Skokie Boulevard STE112
Northbrook, IL 60062
Showing of trademarks Trademarks
Trademark Classifications
AFG Bioscience LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does AFG Bioscience LLC have?
AFG Bioscience LLC has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 pending.
What trademark classes does AFG Bioscience LLC file in?
AFG Bioscience LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are AFG Bioscience LLC's most well-known trademarks?
AFG Bioscience LLC's registered trademark portfolio includes well-known marks such as SIMPLEPHASE, AFG BIOSCIENCE, and AFG SCIENTIFIC. These are among 5 currently registered trademarks in the portfolio.
What is AFG Bioscience LLC's trademark registration success rate?
AFG Bioscience LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 2 applications are pending review.